lumasiran

CHEBI:CHEBI_752302

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2467158
generic_name
LUMASIRAN
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
marketing_start_date
20201123
package_marketing_start_date
23-NOV-20
labeler_name
BioSpring GmbH
manufacturer_name
Alnylam Pharmaceuticals, Inc.
active_ingredient_strength
94.5 mg/.5mL
brand_name
OXLUMO
brand_name_base
OXLUMO
product_ndc
82613-001
application_number
NDA214103
spl_id
edb008d7-c9a8-72f7-e053-2995a90ac947
active_ingredient_name
LUMASIRAN
package_ndc
82613-001-01
package_description
1 BOTTLE in 1 BAG (82613-001-01) / 150 g in 1 BOTTLE
unii
RZT8C352O1
spl_set_id
16985a31-f5e4-4557-9266-fc78d4bc5055
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class